Canadian Orphan Drug Market: myths and realities – Medunik Canada

In Orphan Drug Congress by Cameron

Eric Gervais, Executive Vice President of Medunik Canada gives his presentation on ‘Myths and realities of the Canadian orphan drug market’ at the World Orphan Drug Congress 2013.

The annual World Orphan Drug Congress Europe is the region’s largest event dedicated to dedicated to scientific, commercialisation and business development: an exhibition, a strategic keynote conference and real life case studies.

Part of the family-owned Le Groupe Pharmaceutique Boivin, and based in Montreal, Medunik Canada specialise in bringing drugs to market in Canada.

Visit Medunik Canada.